Arrowhead Publishers and Conferences

Dr. Andreas Jeromin, Chief Medical Officer at Quanterix Corporation will be presenting the company's latest single-molecule array technology (Simoa) for the detection of CNS biomarkers.

The second keynote presentation at Arrowhead Publishers' 3rd Annual Translational Microbiome Conference will be given by Dr. Rita Colwell, Distinguished Professor at Johns Hopkins Bloomberg School of Public Health and founder of CosmosID.

Michael Chopp, Scientific Director of the Neuroscience Institute at Henry Ford Health System, will be presenting on his team's latest work in treating neurological diseases and Injury at Arrowhead Publishers' 7th Annual Traumatic Brain Injury Conference.

Joni Rutter, Director of Programs and Strategic Implementation at the All of UsSM Research Program, will be presenting at Arrowhead Publishers' Neuroscience in Intensive Care International Symposium (NICIS) – America. Dr.

Arrowhead Publishers is pleased to announce that Walter Koroshetz, MD, Director, National Institute of Neurological Disorders and Stroke (NINDS), NIH will be the keynote presenter at Arrowhead Publishers' Neuroscience in Intensive Care International...

Several esteemed presenters have been announced for Arrowhead's 7th Annual Traumatic Brain Injury Conference, taking place in Washington, DC on May 24-25, 2017.

Jack Gilbert, the faculty director of The Microbiome Center and professor at the University of Chicago, has just been announced as the keynote speaker at Arrowhead Publishers' 3rd Annual Translational Microbiome Conference.

Arrowhead Publishers has announced the preliminary speaking faculty for the 3rd Annual Translational Microbiome Conference.

Cara Therapeutics has recently resumed clinical trials for its novel kappa opioid receptor agonist CR845 in managing acute and chronic pain.

Novartis, Pfizer and Thermo Fisher to Lead Panel Discussion on Developing a Universal Test NGS-Based Companion Diagnostic Designed to Support Multiple Drug Development Programs